Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:90309552
Filing Date:11/10/2020
NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular
application.
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:90309552
Filing Date:11/10/2020
To the Commissioner for Trademarks:
MARK: ZyeSAMI (Standard Characters, see mark)
The literal element of the mark consists of ZyeSAMI. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, NeuroRx, Inc., a corporation of Delaware, having an address of
1201 North Market Street - Suite 111
Wilmington, Delaware 19801
United States
202-340-1352(phone)
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005: Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for treating respiratory diseases
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).
For informational purposes only, applicant's website address is: www.neurorxpharma.com
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $225 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Jonathan C. Javitt/ Date: 11/10/2020
Signatory's Name: Jonathan C. Javitt
Signatory's Position: CEO
Signatory's Phone Number: 202-340-1352
Payment Sale Number: 90309552
Payment Accounting Date: 11/10/2020
Serial Number: 90309552
Internet Transmission Date: Tue Nov 10 12:02:32 ET 2020
TEAS Stamp: USPTO/FTK-XX.XXX.XXX.XX-2020111012023256
3364-90309552-750d2dc7b27c94f2dcf239c71d
abe6232de33b5cc72c71e1b5c8d8ee9a1766586-
CC-02311334-20201110114635423244